Tatva Chintan Pharma Chem Limited, Gujarat, India, announced the rescheduling of its Q4FY25 Earnings Call in collaboration with ICICI Securities.
Tatva Chintan Pharma Chem Limited, headquartered in Gujarat, India, is a leading specialty chemical manufacturing company engaged in producing phase transfer catalysts, structure-directing agents, and electrolyte salts. The company has announced the rescheduling of its earnings call for the fourth quarter and financial year ending March 31, 2025.
Earlier scheduled for May 2, the Earnings Call has now been moved to May 5, 2025, at 5:00 PM IST. The event will be hosted by ICICI Securities and will feature participation from key company executives, including Mr. Chintan Shah (Managing Director), Mr. Ashok Bothra (Chief Financial Officer), and Mr. Ajesh Pillai (Investor Relations).
This update was communicated to both BSE Limited and the National Stock Exchange of India Limited under the respective scrip codes and symbols. The company has also confirmed that the updated information is available on its official website at www.tatvachintan.com.
The rescheduling aims to accommodate better interaction with investors and analysts regarding the company’s financial performance and outlook.
For those interested in attending, Tatva Chintan has shared a Diamond Pass registration link for seamless access to the conference call:
Click here for the Diamond Pass Registration Link
